About

Professor Rachel Elliott is an internationally recognised health economist and Professor of Health Economics at the University of Manchester, where she leads the Manchester Centre for Health Economics. She brings a wealth of expertise in evaluating health policy, digital health interventions, and patient safety initiatives. As an Honorary Professor at the Centre for the Business and Economics of Health (CBEH), she contributes valuable international insights to the Centre’s research and strategic engagement.

Her research focuses on improving the safety, quality, and efficiency of healthcare through economic evaluation and implementation science. She works across a broad range of topics, including medication safety, diabetes, antibiotic stewardship, dementia, and mental health. Her work informs health policy, service design, and clinical decision-making, ultimately aiming to enhance patient care and health system performance.

Research interests 

  • Medication safety and adherence – Evaluating interventions to improve patient outcomes and reduce medication-related harm.
  • Digital health technologies – Assessing the cost-effectiveness and implementation of technology in healthcare delivery.
  • Chronic disease management – Focusing on diabetes and mental health to support evidence-based models of care.
  • Dementia and ageing – Exploring person-centred care strategies and service design for ageing populations.

Research impact 

Rachel has led large-scale applied health economics research programs, securing over £58 million in funding. Her work with the NHS and international collaborators has informed national policy, with notable contributions such as the PINCER trial and the New Medicine Service. She has published extensively and plays a key role in building health economics capability through supervision, mentorship, and collaborative partnerships. Her cross-sector engagement spans clinical, academic, and policy domains, helping to strengthen health systems and improve patient outcomes.